MFDS
- Marketing authorisation holder: BEIGENE
- Status: likely_approved
🇰🇷 Tevimbra in South Korea
Tevimbra (TISLELIZUMAB) regulatory status in South Korea.
Marketing authorisation
Tevimbra in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Tevimbra approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Tevimbra in South Korea?
BEIGENE holds the South Korean marketing authorisation.